SUBSCRIBE
SUBSCRIBE

Australia

This Biotech Aims To Transform The Diagnosis Of Mental Illness. Michael Phelps Backs It. Can It Really Work?
July 21, 2017
 · 
1 min read
Ansell Implements $100 Million Restructuring After Sale of Condom Biz
July 20, 2017
 · 
1 min read
Genetown
Why You Should Always Question the Hiring Manager During An Interview
July 19, 2017
 · 
1 min read
Genetown
5 Tips for Increasing Your Chance Of Being Headhunted
July 19, 2017
 · 
1 min read
Genetown
5 Key Elements Of A Resume That Will Make A Great First Impression
July 19, 2017
 · 
1 min read
Genetown
How A Scientist With A PhD Is An Advantage At A Job Interview
July 19, 2017
 · 
1 min read
Genetown
How To Advance Your Scientific Career By Working For A CRO
July 19, 2017
 · 
1 min read
Science May Just Have Found A Way To Treat The Flu And Common Cold, Nature Communications Reveals
July 13, 2017
 · 
1 min read
Job Trends
AstraZeneca PLC Sold Its U.S. HQ But Will Spend $100 Million Expanding Its Australia Facility
July 12, 2017
 · 
1 min read
Let's Get Rid Of Clinical Trials - Part 2
BioMidwest
BioPharm Executive: And So It Continues: Let’s Get Rid of Clinical Trials (Part 2)
July 7, 2017
 · 
4 min read
Load More
PRESS RELEASES
Immuron achieves record half yearly Travelan® sales
January 16, 2024
 · 
2 min read
Drug Development
GC Cell’s Promising AB-201 Cancer Treatment to Begin Phase 1 Trials Using Lunit AI Platform
January 8, 2024
 · 
4 min read
Policy
Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement
January 5, 2024
 · 
1 min read
Genetown
Bionomics to Present at Biotech Showcase™ 2024The Company will provide an update on its leading asset BNC210 and their partnership strategy
January 5, 2024
 · 
3 min read
Telix Announces Planned Registered Public Offering and Listing in the United States
January 4, 2024
 · 
4 min read
FDA
Immunexpress Announces U.S. FDA Clearance of EDTA Blood Compatible Cartridges for SeptiCyte RAPID®
January 4, 2024
 · 
4 min read
Drug Development
First Patient Dosed in Trial Evaluating Efti and the Anti-PD-L1 Therapy BAVENCIO® in Metastatic Urothelial Cancer
January 4, 2024
 · 
4 min read
Telix to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 3, 2024
 · 
4 min read
Drug Development
GPN Vaccines Reports Positive Safety and Immunogenicity Data from its Phase 1 Trial of Gamma-PN
January 3, 2024
 · 
3 min read
Biotech Beach
BiVACOR Names Veteran Medical Device Executive Jim Dillon as Chief Executive Officer
January 3, 2024
 · 
3 min read
Mayne Pharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 29, 2023
 · 
1 min read
Opthea to Receive US$35M Commitment and Additional US$50M Funding
December 27, 2023
 · 
8 min read
Drug Development
First patient dosed in Clarity’s registrational Phase III prostate cancer trial with Cu-64 SAR-bisPSMA
December 22, 2023
 · 
6 min read
Immuron Clinical Trials Update
December 22, 2023
 · 
3 min read
Drug Development
Immutep Receives Constructive Regulatory Feedback on TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancer
December 21, 2023
 · 
3 min read
Business
Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officer
December 21, 2023
 · 
3 min read
Lone Star Bio
Colossal Announces the Tasmania Thylacine Advisory Committee
December 20, 2023
 · 
4 min read
Recce Pharmaceuticals Awarded AusIndustry Advanced Overseas Finding for Synthetic Anti-Infective Research & Development Program
December 19, 2023
 · 
3 min read
Drug Development
Sapient Therapeutics Announces Positive Phase 1 Results in Part B of Its Solid Dose Prescription CBD Study
December 19, 2023
 · 
2 min read
Opthea Receives A$8.8 million R&D Tax Incentive
December 19, 2023
 · 
2 min read
Load More